Dennis Polk, a Hyve Solutions executive, has demonstrated a clear selling bias in his recent insider transactions, primarily involving shares of TD Synnex (SNX). Since November 2025, Polk has executed 17 sales totaling approximately $9.89 million, with no offsetting purchases during this period. His most significant disposals occurred on January 12, 2026, when he sold SNX shares worth $1.79 million, $1.11 million, and $94,441 in separate transactions, supplemented by smaller sales earlier that month totaling $399,754 across five filings. The pattern extends to late 2025, including an October 9, 2025, sale of $2.30 million in SNX stock alongside smaller dispositions. While Polk has also engaged in acquisitions through derivative securities—such as a $432,325 option exercise in October 2025—these were immediately followed by sales, reinforcing the net reduction in his position.
Polk’s activity spans two companies, with a single non-monetary award filing for Concentrix (CNXC) in March 2026 and all monetary transactions focused on SNX. The consistency and scale of his disposals, particularly the multi-million-dollar sales clustered in early 2026, suggest an ongoing effort to unwind holdings. The absence of open-market purchases during this period contrasts with his historical activity, which includes $3.78 million in lifetime buys. Notably, even derivative acquisitions like the January 20, 2026, option exercise for $46,812 were dwarfed by concurrent sales, further emphasizing the directional trend. Polk’s filings reflect a disciplined, sequential approach to reducing exposure, with no recent indications of accumulation.
AI-assisted summary